title: Conformation as therapeutic target in the prionoses and other neurodegenerative conditions.
abstract: Neurodegenerative conditions are increasing in prevalence as the average human life expectancy rises. Alzheimer's disease (AD) is the fourth commonest cause of death in the United States; the recent outbreak of new variant Creutzfeldt-Jakob disease (nvCJD) has raised the specter of a large population being at risk to develop this prionosis. The pathogenesis of many neurodegenerative diseases is now recognized to be associated with abnormalities of protein conformation. A common theme in these disorders is the conversion of a soluble normal precursor protein into an insoluble, aggregated, ?-sheet rich form that is toxic. In AD, a critical event is the conversion of the normal, soluble A? (sA?) peptide into fibrillar A?, within neuritic plaques and congophilic angiopathy (1). Similarly, in the prionoses, the central event is the conversion of the normal prion protein, PrPC, to PrPSc (2). An increased ?-sheet content characterizes both A? and PrPSc.
authors.affiliation: Departments of Neurology and Pathology, New York University Medical Center, New York, NY.
authors.forename: T
authors.initials: T
authors.lastname: Wisniewski
authors.forename: E M
authors.initials: EM
authors.lastname: Sigurdsson
authors.forename: P
authors.initials: P
authors.lastname: Aucouturier
authors.forename: B
authors.initials: B
authors.lastname: Frangione